FDA approves Linvatec's tissue fixation device:
This article was originally published in Clinica
Linvatec has received premarket approval from the US FDA for its Endopearl tissue fixation device. The bioabsorbable product, used in knee ligament repair, is designed to strengthen attachment of the ligament graft within the femoral socket. According to Conmed, Linvatec's Utica, New York-based parent, Endopearl increases the fixative strength by up to 50% compared to current methods.